RWJ-25730

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameRWJ-25730
Drug Alias NameRWJ-25730
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1a (5-HT1a) receptor antagonistsDopamine D2 receptor antagonists
TargetsSerotonin 1a (5-HT1a) receptorDopamine D2 receptor
Therapy Area/IndicationsMental Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohnson & Johnson
Active IndicationsN/A
Inactive IndicationsMental Disorders

Other Information

ATC CodeN/A
Related LinksN/A